Naseri, S, Steiniche, T, Ladekarl, M, Hölmich, L R, Langer, S W, Tabaksblat, E M, Junker, N & Chakera, A H 2021, ' Merkelcellekarcinom ', Ugeskrift for Laeger, bind 183, V03210260 . < https://ugeskriftet-dk.auh.aub.aau.dk/videnskab/merkelcellekarcinom >
Blackhall, F, Jao, K, Greillier, L, Cho, B C, Penkov, K, Reguart, N, Majem, M, Nackaerts, K, Syrigos, K, Hansen, K, Schuette, W, Cetnar, J, Cappuzzo, F, Okamoto, I, Erman, M, Langer, S W, Kato, T, Groen, H, Sun, Z, Luo, Y, Tanwani, P, Caffrey, L, Komarnitsky, P & Reinmuth, N 2021, ' Efficacy and Safety of Rovalpituzumab Tesirine Compared with Topotecan as Second-Line Therapy in DLL3-High Small Cell Lung Cancer : Results from the Phase 3 TAHOE Study ', Journal of Thoracic Oncology, vol. 16, no. 9, pp. 1547-1558 . https://doi.org/10.1016/j.jtho.2021.02.009
Binderup, T, Knigge, U, Johnbeck, C B, Loft, A, Berthelsen, A K, Oturai, P, Mortensen, J, Federspiel, B, Langer, S W & Kjaer, A 2021, ' 18 F-FDG-PET is superior to WHO grading as prognostic tool in neuroendocrine neoplasms and useful in guiding peptide receptor radionuclide therapy : a prospective 10-year follow-up study of 166 patients ', The Journal of Nuclear Medicine, vol. 62, no. 6, pp. 808-815 . https://doi.org/10.2967/jnumed.120.244798